HomePCVX • NASDAQ
add
Vaxcyte Inc
Previous close
$60.62
Day range
$59.39 - $61.92
Year range
$41.57 - $82.04
Market cap
6.59B USD
Avg Volume
630.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 121.68M | 91.38% |
Net income | -180.80M | -131.65% |
Net profit margin | — | — |
Earnings per share | -1.82 | -77.73% |
EBITDA | -195.79M | -128.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.08B | 15.98% |
Total assets | 1.41B | 39.93% |
Total liabilities | 167.45M | 218.56% |
Total equity | 1.24B | — |
Shares outstanding | 108.41M | — |
Price to book | 4.66 | — |
Return on assets | -33.86% | — |
Return on capital | -36.61% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -180.80M | -131.65% |
Cash from operations | -128.81M | -97.50% |
Cash from investing | -13.93M | 61.27% |
Cash from financing | 2.74M | -99.58% |
Net change in cash | -147.68M | -126.55% |
Free cash flow | -90.98M | -90.09% |
About
Founded
2013
Headquarters
Website
Employees
254